Luminopia
Aspen, US · Founded 2015 · Delaware corporation · 6 known investors
Luminopia develops software-based therapeutics for neuro-visual disorders that stem from deficiencies in the brain rather than the eyes, generating therapeutic visual stimuli delivered through a virtual reality headset. Its lead product treats amblyopia, and serves as proof-of-concept for a broader platform targeting conditions such as brain-based vision loss in patients.
Founders & leadership
DA
DEAN A. TRAVERSExecutive Officer, Director
SX
SCOTT XIAOExecutive Officer, Director
AW
ALEXANDER WENDLANDExecutive Officer, Director
SX
Scott XiaoCo-Founder & CEO
DT
Dean TraversCo-Founder
BR
Brion RaymondCBO
DM
Drew MoweryVP of Commercial Strategy
HW
Hank WuCOO
SA
Sunny AtwalVP of Engineering
Investors · 6
Reported raises · per SEC filings
Form D private placements▶$15.8MraisedJun 2023 · 10 investors · BiotechnologyRule 506(b)
▶$15.8MraisedJun 2023 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott XiaoExecutive Officer, Director
- Casey TanseyDirector
- Robert LangerDirector
- Dean TraversDirector
- William DaiDirector
- Mark JacobsteinDirector
- Offering amount
- $16.8M
- Amount sold
- $15.8M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.1MraisedOct 2022 · 15 investors · BiotechnologyRule 506(b)
▶$4.1MraisedOct 2022 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey DunnDirector
- Scott XiaoExecutive Officer, Director
- Dean TraversDirector
- Robert LangerDirector
- Mark JacobsteinDirector
- Michelle LeeDirector
- William DaiDirector
- Offering amount
- $5.1M
- Amount sold
- $4.1M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.1MraisedDec 2019 · 29 investors · Other Health CareRule 506(b)
▶$11.1MraisedDec 2019 · 29 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott XiaoExecutive Officer
- Mark JacobsteinDirector
- Jeffrey DunnDirector
- Dean TraversExecutive Officer, Director, Promoter
- Joi ItoDirector
- Robert LangerDirector
- Offering amount
- $13.6M
- Amount sold
- $11.1M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3.6MraisedSep 2017 · 8 investors · Other Health CareRule 506(b)
▶$3.6MraisedSep 2017 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- SCOTT XIAOExecutive Officer, Director
- ALEXANDER WENDLANDExecutive Officer, Director
- MARK DOCKSERExecutive Officer
- DEAN A. TRAVERSExecutive Officer, Director, Promoter
- Offering amount
- $5.1M
- Amount sold
- $3.6M
- Minimum investment
- $10K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.3MraisedSep 2017 · 3 investors · Other Health CareRule 506(b)
▶$1.3MraisedSep 2017 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- SCOTT XIAOExecutive Officer, Director
- MARK DOCKSERExecutive Officer
- DEAN A. TRAVERSExecutive Officer, Director, Promoter
- ALEXANDER WENDLANDExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.3M
- Minimum investment
- $25K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$410KraisedDec 2016 · 8 investors · OtherRule 506(b)
▶$410KraisedDec 2016 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- SCOTT XIAOExecutive Officer, Director
- ALEXANDER WENDLANDExecutive Officer, Director
- DEAN A. TRAVERSExecutive Officer, Director
- Offering amount
- $700K
- Amount sold
- $410K
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$250KraisedJul 2016 · 7 investors · OtherRule 506(b)
▶$250KraisedJul 2016 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- DEAN A. TRAVERSExecutive Officer, Director
- SCOTT XIAOExecutive Officer, Director
- ALEXANDER WENDLANDExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $250K
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.